共 50 条
High-Sensitivity and High-Throughput Quantification of Everolimus in Human Whole Blood Using Ultrahigh-Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry
被引:2
|作者:
Miyagi, Chika
[1
]
Tanaka, Ryota
[1
]
Hirata, Kenshiro
[2
]
Watanabe, Takuma
[1
]
Tatsuta, Ryosuke
[1
]
Miyamura, Shigeyuki
[2
]
Itoh, Hiroki
[1
]
机构:
[1] Oita Univ Hosp, Dept Clin Pharm, 1-1 Idaigaoka, Yufu, Oita 8795593, Japan
[2] Sojo Univ, Fac Pharmaceut Sci, Dept Clin Pharmaceut, Kumamoto, Japan
基金:
日本学术振兴会;
关键词:
everolimus;
therapeutic drug monitoring;
ultrahigh-performance liquid chromatography coupled with tandem mass spectrometry;
latex agglutination turbidimetric;
solid-phase extraction;
LC-MS/MS;
POLARIZATION IMMUNOASSAY;
IMMUNOSUPPRESSIVE DRUGS;
HPLC-UV;
TACROLIMUS;
SIROLIMUS;
CYCLOSPORINE;
PHARMACOKINETICS;
THERAPY;
D O I:
10.1097/FTD.0000000000000985
中图分类号:
R446 [实验室诊断];
R-33 [实验医学、医学实验];
学科分类号:
1001 ;
摘要:
Background: Rigorous dose adjustment by therapeutic drug monitoring (TDM) is recommended when everolimus (EVR) is administered for immunosuppression. In this study, the authors developed a highly sensitive ultrahigh-performance liquid chromatography coupled with the tandem mass spectrometry (UHPLC-MS/MS) method for measuring EVR concentrations in whole blood using a high-throughput solid-phase extraction method for sample pretreatment. Furthermore, the blood EVR concentrations in routine TDM samples from patients who underwent renal transplantation measured using the established UHPLC-MS/MS method were compared with those measured using the latex agglutination turbidimetric immunoassay (LTIA). Methods: Blood samples were pretreated by solid-phase extraction using a 96-well HLB mu Elution plate. The clinical application of the newly developed method was evaluated using 87 blood samples from 19 patients who underwent kidney transplant. Results: The calibration curve showed good linearity over a wide range of 0.1-50 ng/mL, with relative error <= 15% obtained from the back calculation of calibrators, and <= 20% for the lower limit of quantification. Within-batch and batch-to-batch accuracies and precisions fulfilled the acceptance criteria of the US Food and Drug Administration guidelines for bioanalytical method validation. The extraction recovery rates were good (>= 65.2%), and almost no matrix effects were found in any of the quality control samples. Blood EVR concentrations measured by UHPLC-MS/MS were positively correlated with those measured by LTIA. A Bland-Altman plot indicated that the UHPLC-MS/MS method yielded better measurements than the LTIA method, regardless of the concentration. Conclusions: Therefore, the authors succeeded in developing a novel high-sensitivity and high-throughput method for measuring blood EVR concentration by UHPLC-MS/MS using a mu Elution plate for sample pretreatment.
引用
收藏
页码:633 / 640
页数:8
相关论文